Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target-Reference-Cited by-同舟云学术

Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target

Published:2003-09 Issue:14 Volume:39 Page:2006-2011
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Verweij J,van Oosterom A,Blay J.-Y,Judson I,Rodenhuis S,van der Graaf W,Radford J,Le Cesne A,Hogendoorn P.C.W,di Paola E.D,Brown M,Nielsen O.S

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Soft tissue sarcomas;Brennan,2001

2. Importance of surgical resection in the successful management of soft tissue sarcoma;Flugstad;Arch. Surg.,1999

3. The local management of soft tissue sarcoma;O'Sullivan;Semin. Radiat. Oncol.,1999

4. Soft tissue sarcomas in adults;Dirix;Curr. Opin. Oncol.,1999

5. Radiation therapy of soft tissue sarcomas;Tepper;Cancer,1985

Cited by 370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance;Cancers;2024-09-07

2. Censorship, industry structure, and creativity: evidence from the Catholic Inquisition in Renaissance Venice;The Journal of Law, Economics, and Organization;2024-05-22

3. Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?;Cancers;2024-02-23

4. Advanced and Metastatic Gastrointestinal Stromal Tumors Presenting With Surgical Emergencies Managed With Surgical Resection: A Case Series;Cureus;2024-02-08

5. Normalization of drug and therapeutic concepts with Thera-Py;JAMIA Open;2023-10-04